Author:
Liu Wuyong,Zhang Jingyu,Qiao Guanyu,Bian Jilong,Dong Benzhi,Li Yang
Abstract
Abstract
Background
The identification of drug side effects plays a critical role in drug repositioning and drug screening. While clinical experiments yield accurate and reliable information about drug-related side effects, they are costly and time-consuming. Computational models have emerged as a promising alternative to predict the frequency of drug-side effects. However, earlier research has primarily centered on extracting and utilizing representations of drugs, like molecular structure or interaction graphs, often neglecting the inherent biomedical semantics of drugs and side effects.
Results
To address the previously mentioned issue, we introduce a hybrid multi-modal fusion framework (HMMF) for predicting drug side effect frequencies. Considering the wealth of biological and chemical semantic information related to drugs and side effects, incorporating multi-modal information offers additional, complementary semantics. HMMF utilizes various encoders to understand molecular structures, biomedical textual representations, and attribute similarities of both drugs and side effects. It then models drug-side effect interactions using both coarse and fine-grained fusion strategies, effectively integrating these multi-modal features.
Conclusions
HMMF exhibits the ability to successfully detect previously unrecognized potential side effects, demonstrating superior performance over existing state-of-the-art methods across various evaluation metrics, including root mean squared error and area under receiver operating characteristic curve, and shows remarkable performance in cold-start scenarios.
Funder
National Natural Science Foundation of China
Key Research and Development Program of Heilongjiang
Natural Science Foundation of Heilongjiang Province
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–9.
2. Whitebread S, Hamon J, Bojanic D, Urban L. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discovery Today. 2005;10(21):1421–33.
3. Yao W, Zhao W, Jiang X, Shen X, He T. MPGNN-DSA: a meta-path-based graph neural network for drug-side effect association prediction. In: 2022 IEEE international conference on bioinformatics and biomedicine (BIBM), 2022; pp. 627–632. IEEE
4. Paci P, Fiscon G, Conte F, Wang R-S, Handy DE, Farina L, Loscalzo J. Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects. npj Syst Biol Appl. 2022;8(1):12.
5. Jiang H, Qiu Y, Hou W, Cheng X, Yim MY, Ching W-K. Drug side-effect profiles prediction: from empirical to structural risk minimization. IEEE/ACM Trans Comput Biol Bioinf. 2018;17(2):402–10.